Research in this area includes the development of new drugs, developing novel methods for undertaking microwave assisted and flow chemistry, new synthetic methods for organic molecules and organic and bio-inorganic catalysis, polymer chemistry.

Our researchers:

Professor Mark Bagley

Our research interests span the breadth of heterocyclic chemistry, developing new methods for the synthesis of heteroaromatic compounds of biological interest and new properties for heterocyclic drugs and natural products.

For more information visit the Bagley Lab website.

Professor Brian Cox

My research interests include:

• • • The prosecution of novel hit and lead optimization programs in a number of therapeutic areas (Respiratory, Neuroscience and developing world diseases).
    • The use of high throughput automated chemistry for hit and lead optimization and the generation of new compound libraries with drug-like properties in novel chemical space.
    • The development of novel chemistries for use on high throughput automated synthesis platforms.

The high throughput chemistry facility has been designed and set up to industry standard. The group collaborates both internally and externally. Internally it is involved in a number of drug discovery initiatives within Life Sciences. Externally, it has major involvements in a joint university company start-up project (Photodiversity Ltd) with the University of Bristol (Professor Kevin Booker-Milburn), with the University of Genève looking at new treatments for Chagas disease (American trypanosomiasis) and with a number of pharmaceutical companies globally.

Dr Barnaby Greenland

Barny is interested in the developement of responsive polymeric and supramolecular materials. Current projects include synthesising materials that can heal themselves when broken or debond two surfaces on demand, as well as producing materials that are conductive or can be used in 2D and 3D printing.

For more information, visit the Greenland Lab website

Dr Cristina Pubill Ulldemolins

Our multidisciplinary research group currently focuses on the use of experimental (in particular, catalytic methods development) and computational approaches to design new bioactive peptides as novel therapeutic leads for the treatment of Alzheimer’s Disease and cancer.

Professor John Spencer

The Spencer group conducts research on the interface of chemistry and medicinal chemistry, making use of transition metal catalysis and microwave-mediated synthesis where possible.

For more information visit the Spencer Lab website

Dr Eddy Viseux

Research in the Viseux group is currently focussing on the development of strategies for the synthesis of complex natural products with interesting biological properties.

For more information visit the Viseux Lab website.